Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Midatech receives £450,000 payment as part of vaccines deal

"I am pleased to see progress being made in the adaptation of our gold nanoparticle technology for use in vaccines for infectious disease,” said chief executive Jim Phillips.
Midatech receives £450,000 payment as part of vaccines deal
The company has received a financial boost from its collaboration.

Midatech Pharma Plc (LOM:MTPH, NASDAQ:MTP) said it had received £450,000 under the terms of its contract with Emergex Vaccines.

The latter is using the former’s gold nanoparticle platform to develop of vaccines for flu, meningitis, bacterial pneumonia, Ebola and a number of other infectious diseases. This is the first deployment of the technology in this setting.

"I am pleased to see progress being made in the adaptation of our gold nanoparticle technology for use in vaccines for infectious disease,” said chief executive Jim Phillips.

 “[This] perfectly complements our type 1 diabetes collaboration in antigen specific immunotherapy, and our early-stage internal programs which address auto-immune disease and immuno-oncology."

Ian_55ae0ddd437b7.jpg
Why Invest In Midatech Pharma Plc? Read More Here

Register here to be notified of future MTPH Company articles
View full MTPH profile

Midatech Pharma Plc Timeline

Big Picture
November 22 2016

Related Articles

GW_Pharma.png
November 22 2016
With the balance sheet now significantly strengthened, we anticipate the company is well-positioned to capture value in areas where its technology platforms offer material improvements for patient care - Panmure Gordon.
picture of drug lab
February 07 2017
Amryt Pharma’s strategy to acquire, in-license and then develop drugs for hard to treat, so-called orphan diseases has been seeing some good progress.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use